Immune activation in patients with irritable bowel syndrome.
about
Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infectionEffect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypesSerum correlates of the placebo effect in irritable bowel syndromeProbiotics and irritable bowel syndromeAcne vulgaris, probiotics and the gut-brain-skin axis - back to the future?An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered MicrobiomeMycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicitiesUse of rifaximin in gastrointestinal and liver diseasesStem Cells in the Intestine: Possible Roles in Pathogenesis of Irritable Bowel SyndromeFunctional dyspepsia: new insights into pathogenesis and therapyInflammation in irritable bowel syndrome: Myth or new treatment target?Gut microbiota and gastrointestinal health: current concepts and future directionsCytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysisThe interplay of the gut microbiome, bile acids, and volatile organic compoundsGut microbiota as potential orchestrators of irritable bowel syndromeImmunomodulation of enteric neural function in irritable bowel syndromeAcne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicineToll-like receptor mRNA expression is selectively increased in the colonic mucosa of two animal models relevant to irritable bowel syndromeThe utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study.TNFalpha: a trigger of autonomic dysfunctionEffect of probiotics on symptoms in korean adults with irritable bowel syndrome.Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.Involvement of interleukin-17A-induced hypercontractility of intestinal smooth muscle cells in persistent gut motor dysfunctionPediatric functional gastrointestinal disorders.Identifying the Ion Channels Responsible for Signaling Gastro-Intestinal Based PainIrritable bowel syndrome and diet.Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndromeImmune activation and gut microbes in irritable bowel syndrome.Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia.Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndromeIntestinal microbiota in pathophysiology and management of irritable bowel syndrome.Methodological issues in the study of intestinal microbiota in irritable bowel syndromeConvergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients.Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial.Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptorsFrom cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome.Effect of Colostrum on the Symptoms and Mucosal Permeability in Patients with Irritable Bowel Syndrome: A Randomized Placebo-controlled Study.Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection
P2860
Q21198942-C346E9CD-DC38-47A7-89B9-3FC5930377CAQ21261902-BC3ABE3F-8AA3-4515-8CC5-432D9AB65E39Q24598909-016AACFD-E59B-479A-93EC-BCEF0B3478CBQ24616349-F46B5B78-786E-4181-80F0-8AE1225D916CQ24624433-724B52BF-5D2E-46BC-9965-4D5193DF25DAQ24630575-307BE604-68D2-4C26-B530-D71FACB11B56Q24681823-4849636F-98D3-435C-B577-B4050B142DFCQ26740201-768FF9B8-5E24-46A9-A290-CBECB5C979F8Q26749356-12E1438D-17F5-4C3B-87AF-E0547ED972B9Q26751475-20839CB9-8B6D-4AAC-BB6C-CAAEDC1BE4C0Q26768545-075C8AD2-1D61-4392-8DC7-1F121B682ABCQ26865880-1B3D65D0-2F30-42AE-B541-2B82AC50B2DCQ27011652-9DB43576-76AD-4FA0-B716-134F9E3A3DEEQ28082012-977E7D0A-B1E1-4BBD-B1C0-5E7B4A934AA7Q28085584-23D7F490-5E7D-401E-8906-D821CFBA6C94Q28086910-66608BF4-3F04-4BAA-B593-CB6FE88CDBD7Q28295293-9B8D32DB-6D81-460D-A2B1-B7225BB03F77Q28749706-45C46CC6-9AC2-4B4E-B86D-1FC2A9318CD7Q30574620-8A74F520-F1FA-4E47-944E-D26BE952EE6AQ33155571-1D9162FF-235B-4697-ABB5-9A421356C899Q33446254-C210C8B6-A543-476E-83DC-6197C2E221A1Q33470217-4BAB8229-0568-4C08-BB93-777AA18564DAQ33555354-200B0294-ECAF-41D3-BC41-E8972BDA35E7Q33567657-3F8B817A-2C6C-44CB-A30B-F27F3E241AAEQ33651592-9710E56D-81F0-4885-8923-E042039DE526Q33664676-05089718-5CC7-44CD-ABEF-21B98A959E4DQ33726873-B04ED180-AA46-43E1-97AA-53C2D3F6FFEFQ33784540-6BB41EDD-4060-43A4-8B59-FFE79534A10BQ33855474-90417245-0AA8-48B7-8F12-55A03BFD9894Q33890449-0F87CEF8-1FA3-4468-BE4E-6DD5A53C4F87Q33917011-64DB0523-CD4C-4A9E-B25B-4FC8249B4A77Q33958729-1E3F5E99-963E-4355-9A56-A5004DDF9CD3Q33958776-4251930F-DFC0-434A-9656-D19867F134BAQ33958801-B94F5DE1-F3EF-454B-9FF5-E3A4230DD042Q33987389-DCBCEC33-52EF-4B68-B4A7-504DB4AE1516Q34158501-BD0AB3EB-2010-4C31-97DA-6A0730E65CD9Q34231605-436C61C9-F9F5-43A6-A557-6CF465681288Q34298260-32B5FE47-4A3D-4A0B-A8D4-089AD802922CQ34378514-9F2D403B-726D-48D0-8735-65C7588385DEQ34415870-D235F69B-12F9-483D-B71B-FACF5458EEDD
P2860
Immune activation in patients with irritable bowel syndrome.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Immune activation in patients with irritable bowel syndrome.
@ast
Immune activation in patients with irritable bowel syndrome.
@en
Immune activation in patients with irritable bowel syndrome.
@nl
type
label
Immune activation in patients with irritable bowel syndrome.
@ast
Immune activation in patients with irritable bowel syndrome.
@en
Immune activation in patients with irritable bowel syndrome.
@nl
prefLabel
Immune activation in patients with irritable bowel syndrome.
@ast
Immune activation in patients with irritable bowel syndrome.
@en
Immune activation in patients with irritable bowel syndrome.
@nl
P2093
P50
P1433
P1476
Immune activation in patients with irritable bowel syndrome.
@en
P2093
Alexander Röth
Birgit Adam
Christoph Bredack
Nicholas J Talley
Sarah Downie-Doyle
Sue Lester
P304
P356
10.1053/J.GASTRO.2007.01.046
P407
P577
2007-01-26T00:00:00Z